Epstein-barr Virus Associated Lymphoma

• CLINICAL_TRIALS trial_result · 2026-03-23
  Clinical Trial Update: Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01) [NA]

  This clinical trial update notes the completion of a study evaluating donor-derived EBV-specific T cells for Epstein-Barr virus-associated l…

• CLINICAL_TRIALS research · 2026-02-02
  Clinical Trial Update: Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders [Phase 2]

  This Phase 2 clinical trial investigates unrelated cord blood transplantation for Epstein-Barr virus–associated lymphoproliferative diseases…

• CLINICAL_TRIALS research · 2025-04-02
  Clinical Trial Update: Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma

  A mechanistic study of the Epstein-Barr virus mRNA vaccine WGc-043 in EBV-positive relapsed/refractory lymphoma; the trial is not yet recrui…

• CLINICAL_TRIALS trial_result · 2025-03-20
  Clinical Trial Update: Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies [Phase 1, Phase 2]

  Phase 1/2 dose-escalation and expansion study of VRx-3996 with valganciclovir in Epstein-Barr virus-associated lymphoma and other EBV-relate…

• CLINICAL_TRIALS research · 2025-03-03
  Clinical Trial Update: EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases [Phase 1, Phase 2]

  This document provides an update on an early-stage study of EBV-Tscm cytotoxic T cells for Epstein-Barr virus–driven lymphomas and post-tran…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2013-11-15
  Clinical Trial Update: Cell Bank of Epstein Barr Virus Specific Cytotoxic T Lymphocytes [Phase 1]

  Phase 1 clinical trial evaluating a cell bank of Epstein-Barr virus-specific cytotoxic T lymphocytes for Epstein-Barr virus-associated lymph…